Ligand Pharmaceuticals Inc (LGND)
79.02
-0.99
(-1.24%)
USD |
NASDAQ |
Apr 17, 16:00
79.09
+0.07
(+0.09%)
After-Hours: 20:00
Ligand Pharmaceuticals Debt to Equity Ratio: 0.00 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.1188 |
| December 31, 2022 | 0.1284 |
| September 30, 2022 | 0.0938 |
| June 30, 2022 | 0.1433 |
| March 31, 2022 | 0.2226 |
| December 31, 2021 | 0.3906 |
| September 30, 2021 | 0.3902 |
| June 30, 2021 | 0.4009 |
| March 31, 2021 | 0.4724 |
| December 31, 2020 | 0.6234 |
| September 30, 2020 | 0.652 |
| June 30, 2020 | 0.647 |
| March 31, 2020 | 0.6715 |
| December 31, 2019 | 0.8328 |
| September 30, 2019 | 0.7425 |
| June 30, 2019 | 0.6254 |
| March 31, 2019 | 0.5961 |
| December 31, 2018 | 1.134 |
| September 30, 2018 | 1.166 |
| June 30, 2018 | 1.301 |
| March 31, 2018 | 0.4577 |
| December 31, 2017 | 0.5363 |
| Date | Value |
|---|---|
| September 30, 2017 | 0.5216 |
| June 30, 2017 | 0.534 |
| March 31, 2017 | 0.541 |
| December 31, 2016 | 0.5741 |
| September 30, 2016 | 0.5673 |
| June 30, 2016 | 0.5291 |
| March 31, 2016 | 0.522 |
| December 31, 2015 | 0.7294 |
| September 30, 2015 | 0.6946 |
| June 30, 2015 | 2.904 |
| March 31, 2015 | 5.650 |
| December 31, 2014 | 7.444 |
| September 30, 2014 | 4.371 |
| June 30, 2014 | 0.042 |
| March 31, 2014 | 0.0888 |
| December 31, 2013 | 0.1836 |
| September 30, 2013 | 0.2761 |
| June 30, 2013 | 0.3965 |
| March 31, 2013 | 0.6114 |
| December 31, 2012 | 1.068 |
| September 30, 2012 | 1.326 |
| June 30, 2012 | 2.399 |
| March 31, 2012 | 1.526 |
| December 31, 2011 | 3.700 |
| September 30, 2011 | 24.86 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2023
0.8328
Maximum
Dec 2019
0.3766
Average
0.3906
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals Inc | 0.6243 |
| ADMA Biologics Inc | 0.9659 |
| Viking Therapeutics Inc | -- |
| Corcept Therapeutics Inc | 0.00 |
| Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 787.22M |
| Total Liabilities (Quarterly) | 86.30M |
| Shareholders Equity (Quarterly) | 700.91M |
| Current Ratio | 14.15 |
| Net Debt Paydown Yield | 1.22% |